Glooko Announces New Diabetes Analytics Platform

Glooko Announces New Diabetes Analytics Platform
Written By:
Ashish Sukhadeve
Published on

Glooko, a leader in diabetes data management, has launched a new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and an assortment of diabetes analytics, charts and graphs.

The application will be available in the US and Canada. It includes support for IDC's Ambulatory Glucose Profile (AGP), an important standard with clinicians. The application further includes the following new features:

•  Insight into factors like exercise, carbs and medication influence glucose levels.

•  Enhanced charts and graphs with new color coding to streamline data for easy interpretation.

•  Enhanced insulin pump reports, bolus tracking features and

•  Modified PDF wizard that provides easy report reviewing and sharing.

Glooko plans to begin the first phase for the European market launch later this year.  The company attributes the launch of the new product to over a year of development and research in the diasend® and Glooko platforms to identify the most insightful analytics features for people with diabetes (PWDs) and clinicians.  Glooko and diasend®, both diabetes data management companies merged in 2016.

"We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today. We listened to our customers' feedback and added new features that will allow users to further separate the data that really matters from background noise. Patients and clinicians can now efficiently gain actionable insights from their data better than ever before", said Sam Wyndbrant, Director of Product Management at Glooko.

Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp

                                                                                                       _____________                                             

Disclaimer: Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.

Related Stories

No stories found.
Sticky Footer Banner with Fade Animation
logo
Analytics Insight
www.analyticsinsight.net